BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22390800)

  • 1. Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension.
    Judd E; Jaimes EA
    Expert Rev Cardiovasc Ther; 2012 Mar; 10(3):293-303. PubMed ID: 22390800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
    Ferdinand KC; Pool J; Weitzman R; Purkayastha D; Townsend R
    J Clin Hypertens (Greenwich); 2011 May; 13(5):366-75. PubMed ID: 21545398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y; Townsend R
    Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
    Townsend RR; Forker AD; Bhosekar V; Yadao A; Keefe DL
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):889-97. PubMed ID: 22142348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
    Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
    J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.
    Littlejohn TW; Trenkwalder P; Hollanders G; Zhao Y; Liao W
    Curr Med Res Opin; 2009 Apr; 25(4):951-9. PubMed ID: 19257800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.
    Jordan J; Engeli S; Boye SW; Le Breton S; Keefe DL
    Hypertension; 2007 May; 49(5):1047-55. PubMed ID: 17353513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
    Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
    Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
    Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.
    Ferdinand KC; Weitzman R; Israel M; Lee J; Purkayastha D; Jaimes EA
    J Am Soc Hypertens; 2011; 5(2):102-13. PubMed ID: 21414565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapy.
    Glorioso N; Thomas M; Troffa C; Argiolas G; Patel S; Baek I; Zhang J
    Curr Vasc Pharmacol; 2012 Nov; 10(6):748-55. PubMed ID: 22303910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients who did not respond fully to amlodipine monotherapy¥.
    Pfeiffer D; Rennie N; Papst CC; Zhang J
    Curr Vasc Pharmacol; 2012 Nov; 10(6):773-80. PubMed ID: 22303911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliskiren and amlodipine in the management of essential hypertension: meta-analysis of randomized controlled trials.
    Liu Y; Chen K; Kou X; Han Y; Zhou L; Zeng C
    PLoS One; 2013; 8(7):e70111. PubMed ID: 23922924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
    Black HR; Aguirre P F; Wright M; Alessi T; Baschiera F
    J Clin Hypertens (Greenwich); 2012 Aug; 14(8):514-21. PubMed ID: 22863159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
    [No Abstract]   [Full Text] [Related]  

  • 16. Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.
    Black HR; Kribben A; Aguirre Palacios F; Bijarnia M; Laflamme AK; Baschiera F
    J Clin Hypertens (Greenwich); 2010 Dec; 12(12):917-26. PubMed ID: 21122057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
    Sureshkumar KK
    Vasc Health Risk Manag; 2008; 4(6):1205-20. PubMed ID: 19337534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
    Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
    Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aliskiren in Latin America in a real-world setting: aliskiren in Latin America Study (ALAS).
    Volman S; Benitez FN; Cedenio H; Giorgi M; Jaramillo N; Molina N; Zilberman J
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):189-96. PubMed ID: 23723254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J; Ulmer HJ; Benduhn H; Klebs S
    Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.